# Comparing Chemoprevention Approaches for School-based Malaria Control

> **NCT05244954** · PHASE4 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 746 (actual)

## Conditions studied

- Malaria,Falciparum
- Anemia in Children

## Interventions

- **DRUG:** Dihydroartemisinin-Piperaquine
- **DRUG:** Chloroquine

## Key facts

- **NCT ID:** NCT05244954
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2022-08-26
- **Final completion:** 2022-08-26
- **Target enrollment:** 746 (ACTUAL)
- **Last updated:** 2022-11-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05244954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05244954, "Comparing Chemoprevention Approaches for School-based Malaria Control". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05244954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*